Zebrabalığı Araştırma Laboratuvarı
Yayınlar

 

  1. F. Y.  Tuncay Et Al. , "Could TGFBI-related corneal dystrophies be mimicked in zebrafish via CRISPR/Cas9-mediated hot spot arginine variations?,"  EUROPEAN JOURNAL OF HUMAN GENETICS , vol.30, no.SUPPL 1, pp.140, 2022                
  2. Yahşi B, Palaz F, Dinçer PR  CRISPR-based epigenome modifiers and their potential roles in the immune responce (Under review)
  3. Çerçi B, Uzay IA, Kara MK, Dinçer P. Clinical trials and promising preclinical applications of CRISPR/Cas gene editing. Life Sci. 2023 Jan 1;312:121204. doi: 10.1016/j.lfs.2022.121204. Epub 2022 Nov 17. PMID: 36403643.
  4. Chopra A, Song J, Weiner J 3rd, Keceli HG, Dincer PR, Cruz R, Carracedo A, Blanco J, Dommisch H, Schaefer AS. RSPO4 is a potential risk gene of stages III-IV, grade C periodontitis through effects on innate immune response and oral barrier integrity. J Clin Periodontol. 2023 Apr;50(4):476-486. doi: 10.1111/jcpe.13758. Epub 2022 Dec 15. PMID: 36507580.
  5. Uzay İA, Dinçer PR (2022) CRISPR-based approaches for the point-of-care diagnosis of COVID19, Acta Medica, 53(1): 1-14, doi.org/10.32552/2022.ActaMedica.626
  6. Kural-Mangıt E, Düz N, Dinçer PR. A cytoplasmic escapee: Desmin is going nuclear. Turkish J Biol. 2021;45:711–9.
  7. Kayman Kürekçi G, Kural Mangit E, Koyunlar C, Unsal S, Saglam B, Ergin B, Gizer M, Uyanik I, Boustanabadimaralan Düz N, Korkusuz P, Talim B, Purali N, Hughes SM, Dincer PR. (2021) Knockout of zebrafish desmin genes does not cause skeletal muscle degeneration but alters calcium flux. Sci Rep, Apr 5;11(1):7505. doi: 10.1038/s41598-021-86974-w.PMID: 33820917
  8. Kural-Mangıt E, Dinçer PR (2021) Physical evidence on desmin-lamin B interaction. Cytoskeleton (Hoboken), Jan;78(1):14-17. doi: 10.1002/cm.21651. Epub 2021 Jan 28.PMID: 33475247
  9. Yaylacıoğlu Tuncay F, Dinçer PR. (2019) Could autosomal dominant TGFBI related corneal dystrophies be modelled in zebrafish by using CRISPR/Cas9: Challenges and Possibilities. World Journal of Opthalmology Vision Research, 1 (3), 1-13
  10. Yaylacıoğlu Tuncay F, Dincer PR  (2018) Genome Editing Technologies:From Bench Side to Bedside. Acta Medica, 49(3): 30 – 40.